BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

The Latest News from BioAgilytix

30 June, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More

25 June, 2020

BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations

In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.

Read More

6 May, 2020

Frank Horling, Ph.D. Joins BioAgilytix Leadership Team as General Manager, Europe

In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.

Read More

29 April, 2020

BioAgilytix Welcomes Jim McNally, Ph.D. to Leadership Team as Chief Scientific Officer

Dr. McNally brings with him an extensive background in bioanalytical assay development and program leadership working for almost 20 years in the pharmaceutical and biotechnology industry.

Read More

12 December, 2019

BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer

Mr. Marasco will provide strategic direction to BioAgilytix’s global business development and marketing functions / teams to further expand worldwide adoption of the company’s premier bioanalytical services.

Read More

27 November, 2019

Immunogenicity Assessment of Gene Therapy Compounds

In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.

Read More

11 November, 2019

Behind the deal: Why a Triangle company is buying its competitor in Cambridge

The Triangle Business Journal covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the Cambridge area of Massachusetts, a known hotbed of biotech innovation.

Read More

6 November, 2019

BioAgilytix Acquires Cambridge Biomedical

Contract Pharma covers BioAgilytix’s recent acquisition of Cambridge Biomedical, a CRO specializing in large molecule bioanalysis based in the biotech hub of Boston, MA.

Read More

5 November, 2019

Triangle-based BioAgilytix Acquires Cambridge CRO, Plans Hiring, More Acquisitions

North Carolina Biotechnology Center covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the world’s major biotech center, as well as its plans for future hiring and acquisitions.

Read More